Stock market today: Indexes edge down as traders hit pause after rally to record highs
Friday could see a surge in trading activity due to triple witch option expirations and S&P index rebalance trades, NYSE's ...
The stock market got exactly what it wanted from the Fed
Stocks have historically reacted well to Fed rate cuts. Since 1971, the first Fed cut has led to positive returns for ...
Stock market today: Indexes close at record highs and tech soars after Fed rate cut
Indexes rallied Thursday, with tech stocks leading the Nasdaq to rise 2.5% as investors continued to digest Wednesday's jumbo ...
The Fed is following its 1995 playbook — and that's great news for stocks and the economy
The Fed's cutting cycle in 1995 sparked an economic boom, with the stock market more than doubling in value by the end of the ...
Trump Media stock drops as lockup expiration set to give the former president clearance to sell shares
With the lockup period set to expire, Trump could start offloading his nearly $2 billion worth of stock, though the former ...
The Fed has poured rocket fuel on the red-hot AI trade
"The Fed finally ripped the band-aid off and cut 50 bps with a dovish dot plot into 2025 that we view as a very bullish ...
Investors should be hesitant to dive into stocks after the rate cut, with election uncertainty looming, Fundstrat's Tom Lee says
Tom Lee has called for a stock rally after rate cuts, but even after the Fed cut 50 basis points, he's wary on stocks ahead ...
TSLA, RIVN, or LCID: Which U.S. EV Stock Is the Top Pick?
In the highly competitive electric vehicle (EV) market, major players such as Tesla (TSLA), Rivian Automotive (RIVN), and ...
Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination
This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...
MoneyHero Group Reports Second Quarter 2024 Results
Total operating costs and expenses increased to US$34.4 million in the second quarter of 2024 from US$25.5 million in the prior year period, driven primarily by increased investment in marketing and ...
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
Morgan Stanley, Jefferies, Citigroup, and Guggenheim Securities acted as joint book-running managers for the offering.
VAT Group AG: Sell Rating Amid Weak DRAM Pricing and Deferred NAND Expenditures
Morgan Stanley analyst Nigel van Putten downgraded the rating on VAT Group AG (VTTGF – Research Report) to a Sell today, setting a price ...